Abstract
A new comparative genome hybridization technology using NotI microarrays is described (Karolinska Institute International Patent WO02/086163). The method is based on comparative genome hybridization of NotI-enriched probes from tumor and normal genomic DNA with radically new NotI microarrays. A total of 181 NotI-binding loci of human chromosome 3 were assayed in 200 human malignant tissue samples from various organs: kidney, lung, breast, ovary, cervix, and prostate. The most significant portion (above 30%) of aberrations (deletions and methylation) were detected in NotI sites located in the MINT24, BHLHB2, RPL15, RARbeta1, ITGA9, RBSP3, VHL, and ZIC4 genes. This indicates that they may be associated with cancer development. Methylation of these genomic loci was confirmed by methylation-specific PCR and bisulfite sequencing. The results confirm that the proposed method can contribute to cancer genomics.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Trevino V., Falciani F., Barrera-Saldaña H.A. 2007. DNA microarrays: A powerful genomic tool for biomedical and clinical research. Mol. Med. 13, 527–541.
Su A.I., Welsh J.B., Sapinoso L.M., Kern S.G., Dimitrov P., Lapp H., Schultz P.G., Powell S.M., Moskaluk C.A., Frierson H.F. Jr., Hampton G.M. 2001. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res. 61, 7388–7393.
Macgregor P.F. 2003. Gene expression in cancer: The application of microarrays. Expert. Rev. Mol. Diagn. 3, 185–200.
Sadikovic B., Andrews J., Rodenhiser D.I. 2007. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells. Toxicol. Appl. Pharmacol. 225, 300–309.
Brena R.M., Huang T.H., Plass C. 2006. Quantitative assessment of DNA methylation: Potential applications for disease diagnosis, classification, and prognosis in clinical settings. J. Mol. Med. 84, 365–377.
Zhou D., Qiao W., Yang L., Lu Z. 2006. Bisulfite-modified target DNA array for aberrant methylation analysis. Anal. Biochem. 351, 26–35.
Sadikovic B., Andrews J., Carter D., Robinson J., Rodenhiser D.I. 2007. Genome-wide H3K9 histone acetylation profiles are altered in benz[a]pyrene treated MCF7 breast cancer cells. J. Biol. Chem. 283, 4051–4060.
Pollack J.R., Perou C.M., Alizadeh A.A., Eisen M.B., Pergamenschikov A., Williams C.F., Jeffrey S.S., Botstein D., Brown P.O. 1999. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genet. 23, 41–46.
Li J., Protopopov A., Wang F., Senchenko V., Petushkov V., Vorontsova O., Petrenko L., Zabarovska V., Muravenko O., Braga E., Kisselev L., Lerman M.I., Kashuba V., Klein G., Ernberg I., Wahlestedt C., Zabarovsky E.R. 2002. NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes. Proc. Natl. Acad. Sci. USA. 99, 10724–10729.
Zabarovsky E.R., Boldog F., Thompson T., Scanlon D., Winberg G., Marcsek Z., Erlandsson R., Stanbridge E.J., Klein G., Sümegi J. 1990. Construction of a human chromosome 3 specific NotI linking library using a novel cloning procedure. Nucl. Acids Res. 18, 6319–6324.
Kashuba V.I., Gizatullin R.Z., Protopopov A.I., Li J., Vorobieva N.V., Fedorova L., Zabarovska V.I., Muravenko O.V., Kost-Alimova M., Domninsky D.A., Kiss C., Allikmets R., Zakharyev V.M., Braga E.A., Sumegi J., Lerman M., Wahlestedt C., Zelenin A.V., Sheer D., Winberg G., Grafodatsky A., Kisselev L.L., Klein G., Zabarovsky E.R. 1999. Analysis of NotI linking clones isolated from human chromosome 3 specific libraries. Gene. 239, 259–271.
Zöchbauer-Müller S., Fong K.M., Virmani A.K., Geradts J., Gazdar A.F., Minna J.D. 2001. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res. 61, 249–255.
Zabarovsky E.R., Lerman M.I., Minna J.D. 2002. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene. 21, 6915–6935.
Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. 1996. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA. 93, 9821–9826.
Warnecke P.M., Stirzaker C., Song J., Grunau C., Melki J.R., Clark S.J. 2002. Identification and resolution of artifacts in bisulfite sequencing. Methods. 27, 101–107.
Toyota M., Ho C., Ahuja N., Jair K.W., Li Q., Ohe-Toyota M., Baylin S.B., Issa J.P. 1999. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 59, 2307–2312.
Yoon D.Y., Buchler P., Saarikoski S.T., Hines O.J., Reber H.A., Hankinson O. 2001. Identification of genes differentially induced by hypoxia in pancreatic cancer cells. Biochem. Biophys. Res. Commun. 288, 882–886.
Feng Q., Balasubramanian A., Hawes S.E., Toure P., Sow P.S., Dem A., Dembele B., Critchlow C.W., Xi L., Lu H., McIntosh M.W., Young A.M., Kiviat N.B. 2005. Detection of hypermethylated genes in women with and without cervical neoplasia. J. Natl. Cancer. 97, 273–278.
Kuroki T., Trapasso F., Yendamuri S., Matsuyama A., Alder H., Mori M., Croce C.M. 2003. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res. 63, 3724–3728.
Wang Q., Yang C., Zhou J., Wang X., Wu M., Liu Z. 2001. Cloning and characterization of full-length human ribosomal protein L15 cDNA which was overexpressed in esophageal cancer. Gene. 263, 205–209.
Kashuba V.I., Li J., Wang F., Senchenko V.N., Protopopov A., Malyukova A., Kutsenko A.S., Kadyrova E., Zabarovska V.I., Muravenko O.V., Zelenin A.V., Kisselev L.L., Kuzmin I., Minna J.D., Winberg G., Ernberg I., Braga E., Lerman M.I., Klein G., Zabarovsky E.R. 2004. RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. Proc. Natl. Acad. Sci. USA. 101, 4906–4911.
Hibi K., Yamakawa K., Ueda R., Horio Y., Murata Y., Tamari M., Uchida K., Takahashi T., Nakamura Y., Takahashi T. 1994. Aberrant upregulation of a novel integrin alpha subunit gene at 3p21.3 in small cell lung cancer. Oncogene. 9, 611–619.
Li J.L., Fei Q., Yu J., Zhang H.Y., Wang P., Zhu J.D. 2004. Correlation between methylation profile of promoter CpG islands of seven metastasis-associated genes and their expression states in six cell lines of liver origin. Ai Zheng. 23, 985–991.
Senchenko V.N., Liu J., Loginov W., Bazov I., Angeloni D., Seryogin Y., Ermilova V., Kazubskaya T., Garkavtseva R., Zabarovska V.I., Kashuba V.I., Kisselev L.L., Minna J.D., Lerman M.I., Klein G., Braga E.A., Zabarovsky E.R. 2004. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene. 23, 5719–5728.
Gray J.W., Collins C. 2000. Genome changes and gene expression in human solid tumors. 2000. Carcinogenesis. 21, 443–452.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © T.V. Pavlova, V.I. Kashuba, O.V. Muravenko, S.P. Yenamandra, T.A. Ivanova, V.I. Zabarovska, E.R. Rakhmanaliev, L.A. Petrenko, I.V. Pronina, V.I. Loginov, O.Y. Yurkevich, L.L. Kisselev, A.V. Zelenin, E.R. Zabarovsky, 2009, published in Molekulyarnaya Biologiya, 2009, Vol. 43, No. 2, pp. 339–347.
Rights and permissions
About this article
Cite this article
Pavlova, T.V., Kashuba, V.I., Muravenko, O.V. et al. Use of NotI microarrays in analysis of epigenetic and structural changes in epithelial tumor genomes by the example of human chromosome 3. Mol Biol 43, 313–320 (2009). https://doi.org/10.1134/S0026893309020137
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893309020137